MECP2 and fibrosis: Investigation of the role of exosomal miRNA molecules demonstrated that miR-22-enriched exosomes were notably successful in decreasing the infarct size and cardiac fibrosis in a murine post-MI model via targeting MECP2 (methyl-CpG-binding protein 2) [55].